Atai Beckley N.V (ATAI)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$4.27
-1.73%
Mkt Cap $873.33M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 6, 2026 | $300.00K | $1.07M | +255.33% | -$0.12 | -$0.05 | +58.33% | — | — |
| Q4 2025 Nov 12, 2025 | $229.17K | $749.00K | +226.83% | -$0.12 | -$0.28 | -133.33% | — | — |
| Q3 2025 Aug 14, 2025 | — | $719.00K | — | -$0.12 | -$0.14 | -16.67% | — | — |
| Q2 2025 May 14, 2025 | — | $1.55M | — | -$0.19 | -$0.15 | +21.05% | — | — |
| Q1 2025 Mar 17, 2025 | $300.00K | -$5.00K | -101.67% | -$0.14 | -$0.24 | -71.43% | — | — |
| Q4 2024 Nov 13, 2024 | $250.00K | $40.00K | -84.00% | -$0.15 | -$0.16 | -6.67% | — | — |
| Q3 2024 Aug 13, 2024 | — | $273.00K | — | -$0.17 | -$0.36 | -111.76% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$0.20 | -$0.17 | +15.00% | — | — |
| Q1 2024 Mar 28, 2024 | $190.00K | $18.00K | -90.53% | -$0.17 | -$0.12 | +29.41% | — | — |
| Q4 2023 Nov 14, 2023 | $160.00K | $87.00K | -45.63% | -$0.20 | -$0.14 | +30.00% | — | — |
| Q3 2023 Aug 10, 2023 | — | $172.00K | — | -$0.21 | -$0.21 | +0.00% | — | — |
| Q2 2023 May 11, 2023 | $10.00K | $37.00K | +270.00% | -$0.22 | -$0.21 | +4.55% | — | — |
| Q1 2023 Mar 24, 2023 | $100.86K | $38.00K | -62.32% | -$0.23 | -$0.28 | -21.74% | — | — |
| Q4 2022 Nov 10, 2022 | $110.00K | $24.00K | -78.18% | -$0.23 | -$0.22 | +4.35% | — | — |
| Q3 2022 Aug 15, 2022 | — | $170.00K | — | -$0.22 | -$0.24 | -9.09% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.25 | -$0.24 | +4.00% | — | — |
| Q1 2022 Mar 30, 2022 | -$18.25K | $230.00K | +1360.27% | -$0.23 | -$0.63 | -173.91% | — | — |
| Q4 2021 Nov 15, 2021 | $266.00K | $266.00K | +0.00% | -$0.28 | -$0.21 | +25.00% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$0.13 | -$0.31 | -138.46% | — | — |
| Q2 2021 May 27, 2021 | — | — | — | — | -$0.57 | — | — | — |